1. Home
  2. DTM vs HALO Comparison

DTM vs HALO Comparison

Compare DTM & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTM
  • HALO
  • Stock Information
  • Founded
  • DTM 2021
  • HALO 1998
  • Country
  • DTM United States
  • HALO United States
  • Employees
  • DTM N/A
  • HALO N/A
  • Industry
  • DTM Oil & Gas Production
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • DTM Utilities
  • HALO Health Care
  • Exchange
  • DTM Nasdaq
  • HALO Nasdaq
  • Market Cap
  • DTM 8.9B
  • HALO 8.0B
  • IPO Year
  • DTM N/A
  • HALO N/A
  • Fundamental
  • Price
  • DTM $96.42
  • HALO $63.76
  • Analyst Decision
  • DTM Buy
  • HALO Buy
  • Analyst Count
  • DTM 12
  • HALO 9
  • Target Price
  • DTM $103.58
  • HALO $61.63
  • AVG Volume (30 Days)
  • DTM 1.4M
  • HALO 1.5M
  • Earning Date
  • DTM 04-29-2025
  • HALO 05-06-2025
  • Dividend Yield
  • DTM 3.40%
  • HALO N/A
  • EPS Growth
  • DTM N/A
  • HALO 63.33
  • EPS
  • DTM 3.60
  • HALO 3.43
  • Revenue
  • DTM $981,000,000.00
  • HALO $1,015,324,000.00
  • Revenue This Year
  • DTM $22.53
  • HALO $20.06
  • Revenue Next Year
  • DTM $7.82
  • HALO $23.87
  • P/E Ratio
  • DTM $26.80
  • HALO $18.60
  • Revenue Growth
  • DTM 6.40
  • HALO 22.44
  • 52 Week Low
  • DTM $60.54
  • HALO $37.73
  • 52 Week High
  • DTM $114.50
  • HALO $66.00
  • Technical
  • Relative Strength Index (RSI)
  • DTM 48.67
  • HALO 59.86
  • Support Level
  • DTM $96.60
  • HALO $63.21
  • Resistance Level
  • DTM $102.12
  • HALO $66.00
  • Average True Range (ATR)
  • DTM 2.49
  • HALO 1.65
  • MACD
  • DTM 0.40
  • HALO -0.12
  • Stochastic Oscillator
  • DTM 46.83
  • HALO 54.45

About DTM DT Midstream Inc.

DT Midstream Inc is an owner, operator, and developer of natural gas midstream interstate and intrastate pipelines; storage and gathering systems; and compression, treatment, and surface facilities. It provides multiple, integrated natural gas services to customers through interstate pipelines, intrastate pipelines, storage systems, lateral pipelines and related treatment plants and compression and surface facilities, and gathering systems and related treatment plants and compression and surface facilities. The segments of the group are Pipeline and Gathering. It generates revenue from pipeline, storage, and gathering systems, substantially all of which are located in the Midwestern U.S., Eastern Canada, Northeastern U.S., and Gulf Coast regions.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: